Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes ...

Suma Krishnan, the President of R&D at Krystal Biotech , Inc. (NASDAQ:KRYS), has executed significant stock sales, according to a recent SEC filing. On December 13, Krishnan... Krish S. Krishnan ...

Pick the best stocks and maximize your portfolio: Krystal Biotech ( (KRYS)) just unveiled an announcement. Krystal Biotech announced promising early clinical results for its genetic medicine ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Sami Corwin has given his Buy rating due to a combination of factors reflecting Krystal Biotech’s promising ...

A month has gone by since the last earnings report for Krystal Biotech, Inc. (KRYS). Shares have added about 6.6% in that time frame, outperforming the S&P 500. Will the recent positive trend ...